Subscribe to industry newsletters

Ascendis Health expands operation with R345 million acquisition

Ascendis Health has expanded its operation into the manufacture and distribution of branded generic prescription, over-the-counter and complementary medicines, with the purchase of Akacia Healthcare for R345 million.

24 Nov 2015 12:40

New partnership to provide vaccines to SA

Cipla Medpro has entered into an exclusive agreement with Serum Institute of India (SII) in South Africa to enable affordable and accessible vaccines for South Africans...

13 Oct 2015 16:23

Adcock Ingram to dispose of loss-making Cosme Farma

SA's second-biggest pharmaceutical manufacturer, Adcock Ingram will dispose of its loss-making Indian business Cosme Farma it announced as it released its annual results...

By Tamar Kahn 27 Aug 2015 10:40

Valeant buys 'female Viagra' maker for $1bn

NEW YORK, USA: Canada's Valeant Pharmaceuticals is paying US$1 billion to buy Sprout Pharmaceuticals, which just won US government approval to sell the first "female Viagra" drug...

21 Aug 2015 16:14

Innovative respiratory inhaler for Obstructive Airway Diseases

Cipla has announced that it is currently developing an innovative inhaler, which will bring important benefits for South African patients and physicians, as the inhaler holds three key benefits for the treatment of Obstructive Airway Diseases (OAD)...

12 Aug 2015 14:43

Ascendis Health expands to Spain with acquisition

Ascendis Health has made its first international acquisition with the purchase of a 49% stake in Spanish pharmaceutical group, Farmalider for R210 million...

4 Aug 2015 08:25

Lupin acquires remaining shares in Pharma Dynamics

Lupin, India's third largest pharmaceutical company (turnover USD 1.83 billion), announced that it had acquired the remaining 40% stake in South African generics major Pharma Dynamics for an undisclosed sum...

17 Mar 2015 16:33

R1.5m allocated to academic medical research

The AstraZeneca Research Trust, a non-profit for the disbursement of academic medical research funding is calling for 2015 research proposals, and awarding R1.5 million to local, high-level, non-interventional studies including doctoral and post-doctoral work...

21 Jan 2015 14:30

Ecsponent Group invests in Swiss biotechnology group

CEO of listed financial services group Ecsponent, Terence Gregory, says the field of regenerative medicine is exploding, hence the group's investment in Geneva-based biotechnology group, Salveo Swiss Technologies.

12 Jan 2015 17:19

Tender to supply ARVs awarded to companies

The national Department of Health has announced the names of various pharmaceutical companies that have won the three year tender to supply antiretroviral (ARVs) to millions of patients on treatment in South Africa...

29 Dec 2014 10:05

The 'Pharms race' and post-economic crisis

The economic crisis has had a strong negative impact on drug consumption in Europe, despite an aging population. Governments, as the principal financers, have been forced to curb their health expenditure...

9 Dec 2014 13:35

Ascendis acquires majority share of Scientific Group

The acquisition of the Scientific Group's Diagnostics business by Ascendis will contribute immediate bottom-line benefit while simultaneously allowing the company to entrench its specialist product ranges and deliver organic growth benefits through integration synergies.

30 Oct 2014 16:31

Durban to host 2016 International HIV/Aids conference

Preparations are well underway for the 2016 International HIV/Aids Conference, that will be held in Durban. The city is hosting the conference for the second time.

28 Oct 2014 08:41

Show more